ZYVERSA THERAPEUTICS, INC. (ZVSA) Net income 2023–2025
ZYVERSA THERAPEUTICS, INC. (ZVSA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$25.0MFY2025 · since FY2023: -$98.3M → -$25.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$25.0M | -165.1% |
| FY2024 | -$9.4M | +90.4% |
| FY2023 | -$98.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ZVSA financial trends
ZVSA RevenueZVSA Net marginZVSA Gross profitZVSA Gross marginZVSA Operating incomeZVSA Operating marginZVSA Operating cash flowZVSA Free cash flowZVSA Capital expendituresZVSA Return on equityZVSA Stock buybacksZVSA Dividends paidZVSA Total assetsZVSA Total liabilitiesZVSA Shareholders’ equityZVSA overview →